| Management target | Revenue FY27 |
|---|
| Revenue growth | 5% QoQ INR growth; 1.8% constant currency growth. |
|---|---|
| Margins | EBITDA at 15.4%; pressured by Middle East and ESOP costs. |
| Order book | 12-month backlog at $310M, up 25% YoY in INR. |
| Demand visibility | Positive AI demand; 40+ new AI-led deals closed this quarter. |
| Management confidence | Confident on UK/US; cautious but observant regarding Middle East volatility. |
Growth
Revenue grew 5% QoQ in INR terms and 1.8% in constant currency; 12-month backlog up 25% YoY.
Outlook
Expects FY27 performance to exceed FY26; North America to hit $30M quarterly run rate for margin recovery.
Risks
Middle East instability impacting execution; high bench costs; ESOP and wage hike impacts on near-term margins.
Last quarter's promises, checked
Delivered
- Guided FY27 growth > FY26 → delivered 5% QoQ INR growth (= BEAT)
- Guided stable margin 16-16.1% → delivered 16.1% in Q4 (= BEAT)
- Guided North America turnaround → delivered 2nd quarter positive order growth (= BEAT)
Partly delivered
- Guided AI-led deal scaling → delivered 27 programs but average size remains small at $1M (= PARTIAL)
Missed
- Guided Healthcare growth recovery → delivered QoQ dip due to timing (= MISS)
Earnings Call Transcript filed with BSE, NSE: MASTEK. Summary written with AI assistance from the document.
Mastek Ltd: key numbers
- Share price
- ₹1,582.80
- Market cap
- ₹4,908 Cr
- Revenue (annual)
- ₹3,699 Cr
- Net profit (annual)
- ₹404.0 Cr
- P/E (TTM)
- 11.8×Sector 22.1×
- Promoter holding
- 35.76%+0.00% QoQ
- FII holding
- 7.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mastek Ltd
All →Mastek Capital Structure Change
Bandhan Mutual Fund acquired 18,000 Mastek shares in the open market on September 15, 2026, raising its stake to 5.0544%. No transaction price is disclosed.
Mastek Annual General Meeting
Mastek held its 44th Annual General Meeting on September 07, 2026. The meeting covered adoption of financial statements, dividend declarations, and director re-appointment.
Mastek Management Change
Mastek Limited announced that Ms. Marilyn Jones has ceased to be an Independent Director upon the completion of her tenure, effective September 04, 2026.